Gubra AS (FRA:PI3) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PI3 Gubra AS FRA:PI3
78 GF Score
Price €48.02
GF Value €386.57
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:PI3
78GF Score
Gubra AS FRA:PI3
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gubra AS (FRA:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €48.02 is trading 87.6% below its estimated GF Value™ of €386.57. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for FRA:PI3:

  • Short Ratio:
  • GF Value™: €386.57 vs. price of €48.02 (87.6% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
78GF Score

Get the complete analysis for FRA:PI3

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€48.02
Price
€386.57
GF Value